Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.31 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4060266 | 0.88 | — | — | |
| SCHEMBL4068807 | 0.87 | — | — | |
| SCHEMBL4062502 | 0.87 | — | — | |
| SCHEMBL5856809 | 0.83 | — | — | |
| SCHEMBL5855552 | 0.82 | — | — | |
| SCHEMBL4065065 | 0.81 | — | — | |
| SCHEMBL4063070 | 0.81 | — | — | |
| SCHEMBL4062219 | 0.78 | LMNA (0.30) | LMNA | |
| SCHEMBL4062504 | 0.77 | — | — | |
| SCHEMBL4063199 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1600450-B1 | Silane compound having at least two protected functional groups and method for preparing the same | SHINETSU CHEMICAL CO (JP) | 2009-10-21 | — | — | EP | claimed |
| EP-1600450-B1 | Silane compound having at least two protected functional groups and method for preparing the same | SHINETSU CHEMICAL CO (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-7053233-B2 | Silane compound having at least two protected functional groups and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-05-30 | — | — | US | disclosed |
| EP-1600450-A1 | Silane compound having at least two protected functional groups and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20050234254-A1 | Silane compound having at least two protected functional groups and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234254-A1 | Silane compound having at least two protected functional groups and method for preparing the same | SIN3A, MNS1, RCC1 | LMNA 275/4885LPAR6 3942/4885LPAR1 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.